CAS 20469-65-2

1-bromo-3,5-dimethoxybenzene

Codes: ERDA-014

Application context (from source-drug indications)

Urothelial carcinomaErdafitinibUrinary tract neoplasmErdafitinib

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Erdafitinib	Tier C — Watch / trade	2030

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

ErdafitinibOptimised routesteps: 4total yield: /

2-(1-methyl-1H-pyrazol-4-yl)-7-nitroquinoxaline→2-chloro-7-nitroquinoxaline→ERDA-012→3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-amine→1-bromo-3,5-dimethoxybenzene→N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-amine→N-(2-chloroethyl)propan-2-amine hydrochloride→Erdafitinib

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.